Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

21,804 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
T Cell Defects: New Insights Into the Primary Resistance Factor to CD19/CD22 Cocktail CAR T-Cell Immunotherapy in Diffuse Large B-Cell Lymphoma.
Wang J, Shen K, Mu W, Li W, Zhang M, Zhang W, Li Z, Ge T, Zhu Z, Zhang S, Chen C, Xing S, Zhu L, Chen L, Wang N, Huang L, Li D, Xiao M, Zhou J. Wang J, et al. Among authors: wang n. Front Immunol. 2022 Apr 27;13:873789. doi: 10.3389/fimmu.2022.873789. eCollection 2022. Front Immunol. 2022. PMID: 35572515 Free PMC article.
A phase I study of anti-BCMA CAR T cell therapy in relapsed/refractory multiple myeloma and plasma cell leukemia.
Li C, Cao W, Que Y, Wang Q, Xiao Y, Gu C, Wang D, Wang J, Jiang L, Xu H, Xu J, Zhou X, Hong Z, Wang N, Huang L, Zhang S, Chen L, Mao X, Xiao M, Zhang W, Meng L, Cao Y, Zhang T, Li J, Zhou J. Li C, et al. Among authors: wang j, wang n, wang d, wang q. Clin Transl Med. 2021 Mar;11(3):e346. doi: 10.1002/ctm2.346. Clin Transl Med. 2021. PMID: 33784005 Free PMC article. Clinical Trial.
Clinical Utility of Droplet Digital PCR to Monitor BCR-ABL1 Transcripts of Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Post-chimeric Antigen Receptor19/22 T-Cell Cocktail Therapy.
Guan Y, Zhang M, Zhang W, Wang J, Shen K, Zhang K, Yang L, Huang L, Wang N, Xiao M, Zhou J. Guan Y, et al. Among authors: wang j, wang n. Front Oncol. 2021 Apr 7;11:646499. doi: 10.3389/fonc.2021.646499. eCollection 2021. Front Oncol. 2021. PMID: 33898316 Free PMC article.
CD19/CD22 Chimeric Antigen Receptor T Cell Cocktail Therapy following Autologous Transplantation in Patients with Relapsed/Refractory Aggressive B Cell Lymphomas.
Cao Y, Xiao Y, Wang N, Wang G, Huang L, Hong Z, Meng L, Zhou X, Wang J, Yang Y, Xu H, Zhang S, Xiao M, Chen L, Zheng M, Li C, Mao X, Gu C, Zhang T, Zhang Y, Zhou J. Cao Y, et al. Among authors: wang g, wang j, wang n. Transplant Cell Ther. 2021 Nov;27(11):910.e1-910.e11. doi: 10.1016/j.jtct.2021.08.012. Epub 2021 Aug 20. Transplant Cell Ther. 2021. PMID: 34425260 Free article.
Outcome of aggressive B-cell lymphoma with TP53 alterations administered with CAR T-cell cocktail alone or in combination with ASCT.
Wei J, Xiao M, Mao Z, Wang N, Cao Y, Xiao Y, Meng F, Sun W, Wang Y, Yang X, Chen L, Zhang Y, Zhu H, Zhang S, Zhang T, Zhou J, Huang L. Wei J, et al. Among authors: wang y, wang n. Signal Transduct Target Ther. 2022 Apr 11;7(1):101. doi: 10.1038/s41392-022-00924-0. Signal Transduct Target Ther. 2022. PMID: 35399106 Free PMC article.
Sequential CAR T-Cell Therapy After Autologous Stem Cell Transplantation for the Treatment of Relapsed/Refractory Intravascular Large B-Cell Lymphoma With Central Nervous System Involvement: A Case Report.
Liu W, Li C, Cao Y, Wang N, Huang L, Shang Z, Wang J, Huang L, Xu J, Xiao M, Zhang Y, Zhou J, Chen L, Xiao Y. Liu W, et al. Among authors: wang j, wang n. Front Oncol. 2022 Apr 28;12:817969. doi: 10.3389/fonc.2022.817969. eCollection 2022. Front Oncol. 2022. PMID: 35574341 Free PMC article.
Chimeric Antigen Receptor-Modified T Cell Immunotherapy for Relapsed and Refractory Adult Burkitt Lymphoma.
Wu J, Cao Y, Zhang Q, Liu W, Zhou X, Ming X, Meng F, Zhang Y, Li C, Huang L, Wei J, Zheng M, Zhang S, Zhang T, Zhu X, Wang N, Wang J, Wang G, Zhou J, Liu B, Xiao Y. Wu J, et al. Among authors: wang g, wang j, wang n. Front Immunol. 2022 May 20;13:879983. doi: 10.3389/fimmu.2022.879983. eCollection 2022. Front Immunol. 2022. PMID: 35669773 Free PMC article.
MYC/BCL2/BCL6 triple hit and TP53 deletion in a case of high-grade B cell lymphoma receiving CAR T cell immunotherapy.
Wang J, Shang Z, Wang J, Xu J, Li W, Guan Y, Yang L, Zhang W, Shen K, Zhang M, Wang J, Chen L, Li Q, He C, Wang N, Huang L, Xiao Y, Xiao M, Zhou J. Wang J, et al. Among authors: wang n. J Immunother Cancer. 2021 Jun;9(6):e002029. doi: 10.1136/jitc-2020-002029. J Immunother Cancer. 2021. PMID: 34078654 Free PMC article. No abstract available.
21,804 results
You have reached the last available page of results. Please see the User Guide for more information.